secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tectonic Therapeutic, Inc. (TECX)
CIK:        0001681087
Form:       8-K
Filed at:   2022-06-29T23:59:59+00:00
Accession:  0001193125-22-185087
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVROBIO CSO Christopher Mason to depart June 30; option exercise period extended to 12 months
--------------------------------------------------------------------------------

- Chief Scientific Officer Christopher Mason's employment ends June 30, 2022 per prior agreement.
- Compensation committee extended post-termination exercise period for his time-based stock options and equity awards from 3 to 12 months.
- Company also updated its corporate slide presentation for investor meetings; no new specific data disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681087/000119312522185087/0001193125-22-185087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681087/000119312522185087/d374875d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-185087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer